New Breast Cancer Drug May Slow Lung Cancer Progress
The breast cancer drug tamoxifen can stall the progression of non-small cell lung cancer, according to new reports. Tamoxifen has had an up and down history in research assays, but is largely regarded as one of the oldest known medications that can block the functionality of estrogen in the body. [...]
Read more ›
